Ifp Advisors, Inc Esperion Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$1.46 - $7.3 $64 - $321	44 New	44 $0
Q3 2021 Oct 06, 2021	SELL	$11.34 - $21.37 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$19.4 - $28.71 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$25.12 - $36.89 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$24.2 - $35.76 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$31.18 - $52.71 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$30.04 - $51.31 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	SELL	$27.44 - $73.84 $246 - $664	-9 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$34.47 - $47.53 $310 - $427	9 New	9 $0
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $360 - $482	-9 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$36.99 - $59.11 $29,259 - $46,756	-791 Reduced 98.88%	9 $0
Q1 2017 Jun 03, 2019	BUY	N/A	794 Added 13233.33%	800 $28,000
Q2 2016 Jun 03, 2019	BUY	N/A	6	6 $0

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.